Can Babesia PCR be positive after treatment has started?

Yes. PCR amplifies nucleic acid from both viable and recently killed organisms, so it can remain positive for a short period after therapy begins. Repeat testing to confirm clearance should be timed weeks after treatment completion and interpreted alongside clinical improvement.

Is fasting required for a Babesia PCR test?

No. The test is performed on whole blood and does not require fasting or any special preparation.

Why is EDTA preferred over heparin for this test?

Heparin can inhibit the PCR amplification reaction, leading to false-negative results. EDTA (lavender-top tube) is the anticoagulant of choice for nucleic-acid testing.

Why should practitioners consider co-testing for Lyme disease?

Babesia microti and Borrelia burgdorferi share the same tick vector, Ixodes scapularis, and co-infection is common in endemic regions. Co-infected patients often have more severe or prolonged symptoms, so testing for both pathogens — and for Anaplasma — is standard practice.

How soon are results available?

Typically 3–5 business days from specimen receipt at Quest. Urgent requests may be accommodated if rapid diagnosis is critical.

Who is at highest risk for severe babesiosis?

Asplenic, elderly, and immunocompromised patients are at greatest risk for severe haemolytic anaemia, multi-organ failure, and death. Rapid PCR diagnosis and aggressive therapy, including possible exchange transfusion, are critical in these groups.

Can babesiosis be transmitted via blood transfusion?

Yes. Babesia microti can be transmitted through red-cell transfusion and may cause severe disease in immunocompromised recipients. Screening of blood donors in endemic regions is now performed in some jurisdictions.

BML-LYM-008lyme tick borneUSA

Babesia microti DNA Real-Time PCR

Q: Can a negative PCR rule out babesiosis?

Not always. PCR sensitivity is highest during acute illness; testing very early, after therapy has reduced parasite load, or during a trough of intermittent parasitaemia can yield a false negative. If clinical suspicion is high, repeat PCR, serology, or blood-film microscopy should be pursued.

The Babesia microti DNA Real-Time PCR test detects intraerythrocytic protozoan nucleic acid in whole blood, offering higher sensitivity than microscopy in early or low-grade parasitaemia. Ordered for suspected babesiosis in tick-endemic regions, particularly when blood films are negative, co-infection is likely, or the patient is immunocompromised.

Biomarkers

Blood (whole blood)

Sample

3–5 business days

Turnaround

Fasting

What is the Babesia PCR test?

The Babesia microti DNA Real-Time PCR test detects parasite nucleic acid in whole blood and is ordered when babesiosis is suspected but parasitaemia is too low for microscopic detection or when rapid confirmation is needed. Babesiosis presents with non-specific febrile illness — fever, chills, sweats, headache, myalgia, and fatigue — that can mimic other tick-borne infections or viral syndromes, and co-infection with Borrelia burgdorferi is common in endemic regions. In immunocompetent patients symptoms may be mild or subclinical, but in asplenic, elderly, or immunocompromised individuals babesiosis can cause severe haemolytic anaemia, multi-organ failure, and death. PCR is particularly valuable in the first week of illness, before antibody seroconversion, and when blood films are negative despite high clinical suspicion. It is also the preferred modality when parasitaemia is intermittent or when distinguishing Babesia microti from the rarer Babesia duncani or other species is necessary. Practitioners use PCR to confirm the diagnosis, guide therapy, and — with caution regarding timing — to assess parasitological clearance after treatment.

What does the Babesia PCR test measure?

B. microti DNA(Babesia microti DNA)

Range: Not detected in healthy individuals.Optimal: Not detected. Any detection of B. microti DNA indicates active or recent infection requiring clinical correlation and, in most cases, antimicrobial therapy.Detected/Not Detected

Babesia microti is an intraerythrocytic protozoan parasite transmitted primarily by Ixodes scapularis, the same tick vector responsible for Lyme disease. After inoculation the sporozoites invade red blood cells, where they replicate asexually, causing haemolysis. Parasitaemia is typically low-level and intermittent, peaking during acute infection and waning as host immunity develops. The organism can persist at sub-microscopic levels for weeks to months, and chronic low-grade parasitaemia has been documented in immunocompromised hosts.

Real-time PCR detects Babesia microti DNA directly in whole blood, offering higher sensitivity than microscopy during early infection and in patients with low or intermittent parasitaemia. A positive result confirms active or recent infection and is the test of choice when clinical suspicion is high but blood films are negative. Because PCR amplifies nucleic acid, it can remain positive for a short window after successful treatment as dead or dying organisms clear, so repeat testing to document cure should be timed appropriately and interpreted alongside clinical improvement.

Why is the Babesia PCR test ordered?

Acute febrile illness with haemolytic anaemia, thrombocytopaenia, or elevated liver enzymes in a patient with tick exposure or residence in an endemic area
Suspected babesiosis when Giemsa-stained blood films are negative or inconclusive, particularly in early infection or low-grade parasitaemia
Co-infection work-up in a patient diagnosed with Lyme disease presenting with persistent or severe systemic symptoms
Evaluation of a febrile transfusion recipient or organ transplant recipient, as babesiosis is transmissible via blood products and can cause severe disease in immunocompromised hosts
Immunocompromised, asplenic, or elderly patients with compatible symptoms, in whom rapid diagnosis and treatment are critical
Post-treatment monitoring in selected cases, timed appropriately to distinguish persistent infection from residual nucleic acid clearance
Travel-related fever in a patient returning from babesiosis-endemic regions of the northeastern or upper midwestern United States

Sample collection and turnaround

Sample type

Blood (whole blood)

Fasting required

Collection method

Venipuncture at patient service centre

Turnaround

3–5 business days

Collection notes

Phlebotomy at Quest draw site. EDTA (lavender-top) tube is preferred for PCR; do not use heparin, which can inhibit amplification. Collect during the acute febrile phase when parasitaemia is highest. If the patient has already started antimicrobial therapy, note timing on the requisition, as parasite load may drop rapidly.

Specimen requirements

Minimum 3 mL whole blood in EDTA. Ship refrigerated (2–8 °C); do not freeze whole blood. Ensure the specimen reaches the laboratory promptly, ideally within 24 hours of collection, to preserve nucleic-acid integrity.

What can affect Babesia PCR results?

variableTiming of sample collection relative to symptom onset

Parasitaemia rises during the first week and peaks in the second; PCR sensitivity is highest during acute illness and declines as parasite load falls with host immunity or treatment.

reducesAntiparasitic therapy

Atovaquone–azithromycin or clindamycin–quinine reduce parasite load rapidly; PCR may become negative within days of starting therapy, though nucleic acid can persist briefly after organisms are no longer viable.

variableIntermittent parasitaemia

Babesia replication is asynchronous, and parasitaemia fluctuates; a single negative PCR does not exclude infection if clinical suspicion is high — repeat testing or correlation with serology and blood film may be needed.

elevatesImmunosuppression

Asplenic and immunocompromised patients sustain higher, more persistent parasitaemia, improving PCR sensitivity but also raising the risk of severe disease.

variableCo-infection with other tick-borne pathogens

Simultaneous Borrelia or Anaplasma infection does not directly interfere with Babesia PCR but can complicate the clinical picture and influence the decision to test.

What do Babesia PCR results mean?

Elevated

Not applicable — PCR is a qualitative assay reporting detected or not detected.

Normal

Not detected: No Babesia microti DNA was amplified in the specimen, consistent with absence of infection or parasitaemia below the limit of detection. A negative result does not exclude babesiosis if testing was performed very early, after effective therapy, or during a trough of intermittent parasitaemia. Clinical correlation and, when suspicion remains high, repeat PCR, serology, or blood-film microscopy are warranted.

Reduced

Not applicable.

Note: PCR detects nucleic acid, not viable organisms, so a positive result shortly after initiating therapy may reflect dying parasites rather than treatment failure. Species-level identification should be confirmed if the clinical or epidemiological picture suggests a non-microti Babesia. In endemic areas consider co-testing for Lyme disease and anaplasmosis. Blood-film microscopy remains complementary — it confirms active intraerythrocytic parasites and allows parasite-load quantification, which guides prognosis and the need for exchange transfusion in severe cases.

Frequently asked questions

PCR detects parasite DNA and is more sensitive in early infection or low-grade parasitaemia, while Giemsa-stained blood smears visualise organisms inside red cells and allow quantification of parasite load. The two tests are complementary — PCR confirms the diagnosis when smears are negative, and smears guide severity assessment and the need for exchange transfusion.

How to access the Babesia PCR test

The Babesia PCR reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:

Krause PJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA): 2020 guideline on diagnosis and management of babesiosis. Clin Infect Dis. (2021)
Vannier EG, et al. Human babesiosis. Infect Dis Clin North Am. (2015)
Leiby DA. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev. (2011)
Wormser GP, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the IDSA. Clin Infect Dis. (2006)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.